115 results on '"Pihusch R"'
Search Results
2. Correction:High-risk additional chromosomal abnormalities at low blast counts herald death by CML (Leukemia, (2020), 34, 8, (2074-2086), 10.1038/s41375-020-0826-9)
3. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients
4. Protein C and procollagen III peptide levels in patients with hepatic dysfunction after allogeneic hematopoietic stem cell transplantation
5. The impact of antithymocyte globulin on short-term toxicity after allogeneic stem cell transplantation
6. Flow cytometric findings in platelets of patients following allogeneic hematopoietic stem cell transplantation
7. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation
8. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles
9. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease
10. Laboratory markers of veno-occlusive disease in the course of bone marrow and subsequent liver transplantation
11. Levels of the terminal complement complex, C3a-desArg and C1-inhibitor in adult patients with capillary leak syndrome following bone marrow transplantation
12. Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages
13. Possible role of transforming growth factor beta-1 in the pathogenesis of veno-occlusive disease of the liver after bone marrow transplantation: V273
14. The course of peripheral blood dendritic cells in patients undergoing allogeneic hematopoietic cell transplantation: 832
15. Mixed chimerism of peripheral blood type 2 dendritic cells after allogeneic hematopoietic cell transplantation is associated with an increased incidence of acute graft-versus-host disease: 816
16. Influence of activated platelets and monocytes on the synthesis of blood coagulation mediators by cultured human endothelial cells: 675
17. Hemostatic complications in bone marrow transplantation: A retrospective analysis of 447 patients: 542
18. Allogeneic stem cell transplantation after chemotherapy and dose-reduced conditioning for high-risk AML and MDS: 500
19. Platelet flow cytometric findings in patients undergoing conditioning therapy for allogeneic hematopoietic stem cell transplantation: 334
20. Lineage specific chimerism analysis of different hematopoietic cell lines after allogeneic hematopoietic cell transplantation: 329
21. Bewusstseinsstörung oder -trübung
22. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy
23. Clearance of platelet microparticles in vivo
24. Characterization of 35 new cases with four different MPLW515 mutations and essential thrombocytosis or primary myelofibrosis
25. Vinorelbin (i.v. plus oral) in Kombination mit Trastuzumab in der Erstlinientherapie des HER-2/neu überexprimierenden, metastasierten Mammakarzinoms: Phase-II-Studie der AIO
26. Oral and intravenous vinorelbine plus trastuzumab for 1st-line treatment of HER2-overexpressing metastatic breast cancer (MBC). A trial of the german AIO breast cancer group
27. Kinetics of dendritic cell chimerism and T cell chimerism in allogeneic hematopoietic stem cell recipients
28. Platelet function differs between patients with cholestatic and non-cholestatic liver disease
29. The Relevance of Plasminogen Activator Inhibitor 1 (PAI-1) as a Marker for the Diagnosis of Hepatic Veno-Occlusive Disease in Patients after Bone Marrow Transplantation
30. Die Heparin-induzierte Thrombozytopenie
31. 846 Neoadjuvant systemic chemotherapy combined with regional hyperthermia in advanced or recurrent soft tissue sarcoma: Results of the RHT-91 study
32. FOLFOXIRI Plus Cetuximab or Bevacizumab as First-Line Treatment of BRAF V600E -Mutant Metastatic Colorectal Cancer: The Randomized Phase II FIRE-4.5 (AIO KRK0116) Study.
33. Characteristics and outcomes of patients with cancer and COVID-19: results from a cohort study.
34. [Unconsciousness and clouded awareness].
35. Microparticles for diagnosis of graft-versus-host disease after allogeneic stem transplantation.
36. Surveillance of megakaryocytic function by measurement of CD61-exposing microparticles in allogeneic hematopoietic stem cell recipients.
37. Cellular origin of platelet-derived microparticles in vivo.
38. Extensive local and systemic therapy in extraneural metastasized glioblastoma multiforme.
39. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients.
40. Evaluation of C-reactive protein, interleukin-6, and procalcitonin levels in allogeneic hematopoietic stem cell recipients.
41. Diagnosis of hepatic veno-occlusive disease by plasminogen activator inhibitor-1 plasma antigen levels: a prospective analysis in 350 allogeneic hematopoietic stem cell recipients.
42. Peripheral dendritic cell chimerism in allogeneic hematopoietic stem cell recipients.
43. Transforming growth factor beta-1 released from platelets contributes to hypercoagulability in veno-occlusive disease following hematopoetic stem cell transplantation.
44. Impact of thrombophilic gene mutations and graft-versus-host disease on thromboembolic complications after allogeneic hematopoietic stem-cell transplantation.
45. Hemostatic complications in bone marrow transplantation: a retrospective analysis of 447 patients.
46. Platelet function rather than plasmatic coagulation explains hypercoagulable state in cholestatic liver disease.
47. Impact of thrombophilic gene mutations on thrombosis risk in patients with gastrointestinal carcinoma.
48. Factor XIII activity levels in patients with allogeneic haematopoietic stem cell transplantation and acute graft-versus-host disease of the gut.
49. Cytoreduction, DLI, or mobilized peripheral blood progenitors.
50. Thrombophilic gene mutations and recurrent spontaneous abortion: prothrombin mutation increases the risk in the first trimester.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.